Thyroid Tablet
Product Images NDC 69680-168

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Thyroid (NDC 69680-168). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vitruvias Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Thyroid 01)

Chemical structure diagram showing the molecular arrangement of the active ingredient in Thyroid tablets, including multiple iodine atoms and functional groups consistent with thyroid hormone components.*

FDA Label Image

Chemical Structure (Thyroid 02)

Chemical structure diagram of the active ingredient in Thyroid tablets, showing its molecular components including iodinated aromatic rings and an amino acid side chain typical of thyroid hormone derivatives.*

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

Label for Thyroid Tablets, USP 15 mg (1/4 grain) by Vitruvias Therapeutics. Each tablet contains levothyroxine (T4) 9.5 mcg and liothyronine (T3) 2.25 mcg. The label indicates a package size of 100 tablets and provides storage and usage directions, including the usual dose range of 15 mg to 180 mg once daily. The label states the product is for prescription use only and is distributed in the USA.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Label for Thyroid Tablets, USP 30 mg (1/2 grain) oral tablets by Vitruvias Therapeutics. The label lists active ingredients levothyroxine (T4) 19 mcg and liothyronine (T3) 4.5 mcg per tablet, with a package count of 100 tablets. Directions for use and storage instructions are present along with distributor and product origin information.*

FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Label)

Label for Thyroid Tablets, USP 60 mg (1 Grain) oral tablets by Vitruvias Therapeutics. The label states each tablet contains levothyroxine (T4) 38 mcg and liothyronine (T3) 9 mcg. The package contains 100 tablets, with storage and usage instructions included. The product is distributed by Vitruvias Therapeutics in Auburn, AL.*

FDA Label Image

Principal Display Panel (90 mg Tablet Bottle Label)

Label for Thyroid Tablets, USP 1 & 1/2 Grain (90 mg) oral tablets by Vitruvias Therapeutics. Each tablet contains 57 mcg levothyroxine (T4) and 13.5 mcg liothyronine (T3). The label states a package count of 100 tablets, includes NDC 69680-168-00, and specifies storage and usage directions.*

FDA Label Image

Principal Display Panel (120 mg Tablet Bottle Label)

Label for Thyroid Tablets, USP, 2 Grain (120 mg) oral tablets by Vitruvias Therapeutics. Contains 100 tablets with active ingredients levothyroxine (T4) 76 mcg and liothyronine (T3) 18 mcg per tablet. Includes storage instructions, distributor information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.